MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 26.226

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.90K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.62 (-1.15%)

USD 54.00B
QQQM Invesco NASDAQ 100 ETF

-0.71 (-0.34%)

USD 38.66B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.15 (-0.27%)

USD 20.93B
ACWI iShares MSCI ACWI ETF

-0.02 (-0.02%)

USD 19.56B
CGABL The Carlyle Group Inc. 4.625% ..

-0.13 (-0.72%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-2.64 (-3.93%)

USD 5.86B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 4.78B
TSLL Direxion Shares ETF Trust - Di..

+1.08 (+4.17%)

USD 4.68B
ETHA iShares Ethereum Trust ETF

-1.29 (-5.22%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

+0.13 (+0.19%)

USD 2.29B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.37% 72% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.37% 72% C 66% D+
Trailing 12 Months  
Capital Gain -9.13% 18% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.13% 17% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.27% 43% F 39% F
Dividend Return 0.27% 36% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.78% 91% A- 98% N/A
Risk Adjusted Return 9.81% 38% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector